acromegaly - dofaq.co
Acromegaly Treatment Market Booming with 7.7% CAGR | Market.us
PharmiWeb.com - 29 Apr 2024
Acromegaly Treatment Market Booming with 7.7% CAGR | Market.us ...
Acromegaly: Symptoms, Treatment, Causes, Complications & Diagnosis
Metropolis Healthcare - 25 Apr 2024
Acromegaly: Symptoms, Treatment, Causes, Complications & Diagnosis ...
Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery
ScienceDirect.com - 13 Feb 2024
Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery ...
Machine learning-based algorithms applied to drug prescriptions and other healthcare services in the Sicilian claims ...
Nature.com - 14 Mar 2024
Machine learning-based algorithms applied to drug prescriptions and other healthcare services in the Sicilian claims ... ...
A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of ...
Cureus - 17 Apr 2024
A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of ... ...
Crinetics (CRNX) Up as Second Acromegaly Study Meets Goals
Yahoo Finance - 20 Mar 2024
Crinetics (CRNX) Up as Second Acromegaly Study Meets Goals ...
Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission
BioSpace - 19 Mar 2024
Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission ...
Crinetics scores phase 3 win with oral treatment for acromegaly
OutSourcing-Pharma.com - 12 Sep 2023
Crinetics scores phase 3 win with oral treatment for acromegaly ...
Crinetics acromegaly drug succeeds in late-stage trial but would face stiff competition if approved
STAT - 10 Sep 2023
Crinetics acromegaly drug succeeds in late-stage trial but would face stiff competition if approved ...
PRIME® Online Activity - Accelerating Acromegaly Care: Patient Perspectives, Clinical Advances, and Personalized ...
PRIME® Continuing Medical Education - 15 Aug 2023
PRIME® Online Activity - Accelerating Acromegaly Care: Patient Perspectives, Clinical Advances, and Personalized ... ...
Rare care of adrenal Cushing's, acromegaly reported in woman, 44
Cushing's Disease News - 09 Feb 2024
Rare care of adrenal Cushing's, acromegaly reported in woman, 44 ...
Crinetics Pharmaceuticals Up on Positive Results for Acromegaly Drug Trial
MarketWatch - 19 Mar 2024
Crinetics Pharmaceuticals Up on Positive Results for Acromegaly Drug Trial ...
Crinetics pads case for oral hormone disorder drug, showing regulation of key biomarker in phase 3
Fierce Biotech - 19 Mar 2024
Crinetics pads case for oral hormone disorder drug, showing regulation of key biomarker in phase 3 ...
Chiesi Global Rare Diseases Launches “Rethink Acromegaly” Campaign to Provide Important Disease Education and ...
Yahoo Finance - 01 Mar 2024
Chiesi Global Rare Diseases Launches “Rethink Acromegaly” Campaign to Provide Important Disease Education and ... ...
Crinetics Aces Phase III in Rare Disease Acromegaly with Once-Daily Pill
BioSpace - 11 Sep 2023
Crinetics Aces Phase III in Rare Disease Acromegaly with Once-Daily Pill ...
The first case report of McCune-Albright syndrome in Syria with late diagnosis
ScienceDirect.com - 08 Feb 2024
The first case report of McCune-Albright syndrome in Syria with late diagnosis ...
Promising Outcomes in Acromegaly Patients Receiving CyberKnife Stereotactic Hypofractionated Radiotherapy
Cureus - 29 Oct 2023
Promising Outcomes in Acromegaly Patients Receiving CyberKnife Stereotactic Hypofractionated Radiotherapy ...
Crinetics' Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 ...
Yahoo Finance - 19 Mar 2024
Crinetics' Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 ... ...
Crinetics Pharmaceuticals Hits Slam Dunk In Acromegaly Treatment; Biotech Stock Surges
Investor's Business Daily - 19 Mar 2024
Crinetics Pharmaceuticals Hits Slam Dunk In Acromegaly Treatment; Biotech Stock Surges ...